HyTEC is the latest successor in a historic line of dose guidelines—following Emami, QUANTEC, and TG-101—that collate published literature on Normal Tissue Complication Probability (NTCP) that forms the basis for routine patient treatments. In 2010, QUANTEC set a new standard for dose-volume information for organs at risk (OARs) within standard 2Gy fractionation regimens. Since the time of its publication, the use of higher fraction doses has become more frequent, necessitating new guidance on OAR dose limits. As Larry Marks, MD commented during a podcast interview, “As the volumes have gone down, the doses have been escalated—a lot!”
Past issues of the HYTEC series, including in-depth, organ-specific analyses, are available for download on the Red Journal website as well as the AAPM website. The group’s findings were organized in a clinically useful table format in a summary review article.
If you’re interested in incorporating the new guidelines, we’ve got you covered. Find bespoke ClearCheck templates designed for the new HyTEC recommendations in our template library, which houses dozens of ready-to-implement templates that can help assess critical dose-volume statistics prescribed by major protocols and task group reports.
Not a ClearCheck user? Visit the product page or check out the video below to discover how to transform patient plan review in your department. From dose constraints and plan checks to collision detection and reporting, ClearCheck is a powerful tool for clinicians that value efficiency.
Written by Tyler Blackwell
Tyler Blackwell is a board-certified medical physicist with extensive clinical experience in radiation therapy. He is active in several AAPM committees, has served as secretary-treasurer for the Northwest Chapter of AAPM, and is an ABR orals examiner. Tyler dabbles in real estate investing and loves preparing breakfast for his two kiddos.
Get the latest news, announcements, and product
updates delivered straight to your inbox.